$ARVN

Arvinas Sees Market Turbulence After Breast Cancer Drug Trial Update with Pfizer

$ARVN Arvinas Inc. (NASDAQ: ARVN), a clinical-stage biopharmaceutical company, faced a sharp market downturn after announcing updated results from a…